This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Fri May 24, 2013 2:04 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 2 posts ] 
Author Message
PostPosted: Tue Jul 17, 2012 2:33 pm 
Offline
Family Elder
User avatar

Joined: Mon Apr 20, 2009 3:00 pm
Posts: 326
http://www.nytimes.com/2012/07/17/healt ... wanted=all

I wonder how it correlates with MS gait & cognitive issues.


Top
 Profile  
 
PostPosted: Tue Jul 17, 2012 2:45 pm 
Offline
Family Elder
User avatar

Joined: Mon Sep 10, 2007 3:00 pm
Posts: 4682
Location: southern California
Both diseases share hippocampal atrophy, hypoperfusion, hypometabolism, mitochondrial dysfunction, slowed cerebral bloodflow, hypoxia and neurodegeneration--which are known to affect gait and cognition.
According to Dr. Peter Stys, Alheimer's and MS share many things in common, but inflammation has thrown researchers off track. Indeed, age of onset may be the major difference between the two diseases.

Quote:
Because diseases such as Alzheimer’s and Parkinson’s have a much more prominent
degenerative rather than inflammatory phenotype, the initial assumption was that a degenerative
mechanism (or mechanisms) was primarily responsible, with inflammation perhaps a secondary,
but possibly important, consequence of the degeneration. In MS, the situation is reversed:
inflammation occurs early and is very prominent in many patients, so it was naturally assumed that
autoimmunity might be causal; but, as we argue throughout this Perspective, such an assumption
may be incorrect. If MS is primarily a degenerative disorder in line with an inside-out mechanism,
why would this disease be unique in engendering such prominent and cyclic inflammation?

The differences may be related to age: Alzheimer’s disease and Parkinson’s disease present decades
later than MS, and immune responsiveness wanes with age through a process of ‘immune
senescence’ (REFS 21,87). Indeed, the responsiveness of T cells, which are known to be centrally
involved in the immunopathogenesis of MS88, appears to be particularly altered with age87.
Moreover, it is conceivable that the putative cytodegeneration involving the myelinating unit
(oligodendroglia, their processes and myelin) in MS releases debris that is more antigenic35,36,66 than
the debris that is shed from the mainly synaptic and neuronal degeneration in Alzheimer’s disease.

From "Will the Real MS Please Stand Up?" Neuroscience, July 2012 opinion piece
cheer

_________________
Husband dx RRMS 3/07
dx dual jugular vein stenosis (CCSVI) 4/09
dual stents placed 5/09
CCSVI in MS


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 2 posts ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Question about cognitive decline

jw2899

8

1017

Sat Jun 18, 2011 10:01 am

LokeRundt View the latest post

There are no new unread posts for this topic. Potential cognitive decline biomarker identified

squiffy2

0

457

Thu Nov 03, 2011 1:37 am

squiffy2 View the latest post

There are no new unread posts for this topic. MS research links brain activity,sharper cognitive decline

squiffy2

0

433

Wed Jan 11, 2012 4:01 am

squiffy2 View the latest post

There are no new unread posts for this topic. Gait aid

Lissiebeth

3

314

Mon Nov 05, 2012 7:10 pm

Lissiebeth View the latest post

There are no new unread posts for this topic. Gait disorders

bromley

0

839

Tue Jan 16, 2007 2:51 pm

bromley View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: